Phillip B. Donenberg, Director at Taysha Gene Therapies, Inc. (TSHA), bought 222,222 shares at $0.90 ($200K) on 2023-08-16, disclosed to the SEC on 2023-08-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.90 | 111,111 | $100K | 50.0% |
| 2 | $0.90 | 111,111 | $100K | 50.0% |
| Total | $0.90 avg | 222,222 | $200K | 100% |
| Filing → |